The dopaminergic response to acute stress in health and psychopathology: A systematic review

Neuroscience and Biobehavioral Reviews

Volumn 56, Issue , 2015, Pages 241-251

  Vaessen, Thomas ^a   Hernaus, Dennis ^a   Myin Germeys, Inez ^a   van Amelsvoort, Thérèse ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Dopamine; Imaging; PET; PFC; Stress; Striatum

Indexed keywords

ACUTE STRESS; AVOIDANCE BEHAVIOR; CANNABIS USE; DOPAMINE METABOLISM; DOPAMINE RELEASE; DOPAMINERGIC ACTIVITY; EVOKED SOMATOSENSORY RESPONSE; GENETIC VARIABILITY; HUMAN; MEDIAL PREFRONTAL CORTEX; MENTAL STRESS; METABOLIC STRESS; MOTOR CONTROL; PERSONALITY; PRIORITY JOURNAL; PSYCHOGENIC PAIN; PSYCHOSIS; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW; VENTRAL STRIATUM; WORKING MEMORY; ANTISOCIAL PERSONALITY DISORDER; BRAIN; METABOLISM; NEUROIMAGING; PATHOLOGY; SCINTISCANNING;

DOPAMINE;

ANTISOCIAL PERSONALITY DISORDER; BRAIN; DOPAMINE; HUMANS; NEUROIMAGING; STRESS, PSYCHOLOGICAL;

EID: 84938079876     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2015.07.008     Document Type: Review

References (124)

1. Aalto S., Bruck A., Laine M., Nagren K., Rinne J.O. Frontal and temporal dopamine release during working memory and attention tasks in healthy humans: a positron emission tomography study using the high-affinity dopamine D2 receptor ligand [11C]FLB 457. J. Neurosci.: Off. J. Soc. Neurosci. 2005, 25:2471-2477.
2. Abercrombie E.D., Keefe K.A., DiFrischia D.S., Zigmond M.J. Differential effect of stress on in vivo dopamine release in striatum, nucleus accumbens, and medial frontal cortex. J. Neurochem. 1989, 52:1655-1658.
3. Adler C.M., Elman I., Weisenfeld N., Kestler L., Pickar D., Breier A. Effects of acute metabolic stress on striatal dopamine release in healthy volunteers. Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol. 2000, 22:545-550.
4. Albin R.L., Young A.B., Penney J.B. The functional anatomy of basal ganglia disorders. Trends Neurosci. 1989, 12:366-375.
5. Arnsten A.F., Cai J.X., Murphy B.L., Goldman-Rakic P.S. Dopamine D1 receptor mechanisms in the cognitive performance of young adult and aged monkeys. Psychopharmacology 1994, 116:143-151.
6. Badgaiyan R.D., Fischman A.J., Alpert N.M. Striatal dopamine release during unrewarded motor task in human volunteers. Neuroreport 2003, 14:1421-1424.
7. Beaufour C.C., Le Bihan C., Hamon M., Thiebot M. Extracellular dopamine in the rat prefrontal cortex during reward-, punishment- and novelty-associated behaviour. Effects of diazepam. Pharmacol. Biochem. Behav. 2001, 69:133-142.
8. Belujon P., Grace A.A. Regulation of dopamine system responsivity and its adaptive and pathological response to stress. Proceedings of Biological sciences 2015, 282. The Royal Society.
9. Bencherif B., Fuchs P.N., Sheth R., Dannals R.F., Campbell J.N., Frost J.J. Pain activation of human supraspinal opioid pathways as demonstrated by [11C]-carfentanil and positron emission tomography (PET). Pain 2002, 99:589-598.
10. Berridge K.C. The debate over dopamine's role in reward: the case for incentive salience. Psychopharmacology 2007, 191:391-431.
11. Berridge K.C., Robinson T.E. What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?. Brain Res. Brain Res. Rev. 1998, 28:309-369.
12. Blanc G., Herve D., Simon H., Lisoprawski A., Glowinski J., Tassin J.P. Response to stress of mesocortico-frontal dopaminergic neurones in rats after long-term isolation. Nature 1980, 284:265-267.
13. Bloomfield M.A., Morgan C.J., Egerton A., Kapur S., Curran H.V., Howes O.D. Dopaminergic function in cannabis users and its relationship to cannabis-induced psychotic symptoms. Biol. Psychiatry 2014, 75:470-478.
14. Bossong M.G., Mehta M.A., van Berckel B.N., Howes O.D., Kahn R.S., Stokes P.R. Further human evidence for striatal dopamine release induced by administration of 9-tetrahydrocannabinol (THC): selectivity to limbic striatum. Psychopharmacology 2015.
15. Brake W.G., Zhang T.Y., Diorio J., Meaney M.J., Gratton A. Influence of early postnatal rearing conditions on mesocorticolimbic dopamine and behavioural responses to psychostimulants and stressors in adult rats. Eur. J. Neurosci. 2004, 19:1863-1874.
16. Breier A. A.E. Bennett award paper. Experimental approaches to human stress research: assessment of neurobiological mechanisms of stress in volunteers and psychiatric patients. Biol. Psychiatry 1989, 26:438-462.
17. Brunelin J., d'Amato T., Van Os J., Costes N., Suaud Chagny M.F., Saoud M. Increased left striatal dopamine transmission in unaffected siblings of schizophrenia patients in response to acute metabolic stress. Psychiatry Res. 2010, 181:130-135.
18. Brunelin J., Fecteau S., Suaud-Chagny M.F. Abnormal striatal dopamine transmission in schizophrenia. Curr. Med. Chem. 2013, 20:397-404.
19. Burghardt P.R., Love T.M., Stohler C.S., Hodgkinson C., Shen P.H., Enoch M.A., Goldman D., Zubieta J.K. Leptin regulates dopamine responses to sustained stress in humans. J. Neurosci.: Off. J. Soc. Neurosci. 2012, 32:15369-15376.
20. Cabib S., Puglisi-Allegra S. The mesoaccumbens dopamine in coping with stress. Neurosci. Biobehav. Rev. 2012, 36:79-89.
21. Carini L.M., Nephew B.C. Effects of early life social stress on endocrinology, maternal behavior, and lactation in rats. Horm. Behav. 2013, 64:634-641.
22. Ceccarini J., Vrieze E., Koole M., Muylle T., Bormans G., Claes S., Van Laere K. Optimized in vivo detection of dopamine release using 18F-fallypride PET. J. Nucl. Med.: Off. Publ. Soc. Nucl. Med. 2012, 53:1565-1572.
23. Cenci M.A., Kalen P., Mandel R.J., Bjorklund A. Regional differences in the regulation of dopamine and noradrenaline release in medial frontal cortex, nucleus accumbens and caudate-putamen: a microdialysis study in the rat. Brain Res. 1992, 581:217-228.
24. Chrapusta S.J., Wyatt R.J., Masserano J.M. Effects of single and repeated footshock on dopamine release and metabolism in the brains of Fischer rats. J. Neurochem. 1997, 68:2024-2031.
25. Corum C.R., Thurmond J.B. Effects of acute exposure to stress on subsequent aggression and locomotion performance. Psychosom. Med. 1977, 39:436-443.
26. De Bellis M.D., Baum A.S., Birmaher B., Keshavan M.S., Eccard C.H., Boring A.M., Jenkins F.J., Ryan N.D., Bennett A.E. Research award. Developmental traumatology. Part I: biological stress systems. Biol. Psychiatry 1999, 45:1259-1270.
27. de Kloet E.R., Joels M., Holsboer F. Stress and the brain: from adaptation to disease. Nat. Rev. Neurosci. 2005, 6:463-475.
28. de la Fuente-Fernandez R., Phillips A.G., Zamburlini M., Sossi V., Calne D.B., Ruth T.J., Stoessl A.J. Dopamine release in human ventral striatum and expectation of reward. Behav. Brain Res. 2002, 136:359-363.
29. Dedovic K., Rexroth M., Wolff E., Duchesne A., Scherling C., Beaudry T., Lue S.D., Lord C., Engert V., Pruessner J.C. Neural correlates of processing stressful information: an event-related fMRI study. Brain Res. 2009, 1293:49-60.
30. DeLong M.R. Primate models of movement disorders of basal ganglia origin. Trends Neurosci. 1990, 13:281-285.
31. Deutch A.Y., Clark W.A., Roth R.H. Prefrontal cortical dopamine depletion enhances the responsiveness of mesolimbic dopamine neurons to stress. Brain Res. 1990, 521:311-315.
32. Dunn A.J. Stress-related activation of cerebral dopaminergic systems. Ann. N. Y. Acad. Sci. 1988, 537:188-205.
33. Farde L., Pauli S., Hall H., Eriksson L., Halldin C., Hogberg T., Nilsson L., Sjogren I., Stone-Elander S. Stereoselective binding of 11C-raclopride in living human brain - a search for extrastriatal central D2-dopamine receptors by PET. Psychopharmacology 1988, 94:471-478.
34. Floresco S.B. Prefrontal dopamine and behavioral flexibility: shifting from an "inverted-U" toward a family of functions. Front. Neurosci. 2013, 7:62.
35. Fusar-Poli P., Meyer-Lindenberg A. Striatal presynaptic dopamine in schizophrenia, part II: meta-analysis of [(18)F/(11)C]-DOPA PET studies. Schizophr. Bull. 2013, 39:33-42.
36. Gepshtein S., Li X., Snider J., Plank M., Lee D., Poizner H. Dopamine function and the efficiency of human movement. J. Cogn. Neurosci. 2014, 26:645-657.
37. Glover D.A., Powers M.B., Bergman L., Smits J.A., Telch M.J., Stuber M. Urinary dopamine and turn bias in traumatized women with and without PTSD symptoms. Behav. Brain Res. 2003, 144:137-141.
38. Goldman-Rakic P.S. The cortical dopamine system: role in memory and cognition. Adv. Pharmacol. (San Diego, Calif.) 1998, 42:707-711.
39. Gray J.A. Dopamine release in the nucleus accumbens: the perspective from aberrations of consciousness in schizophrenia. Neuropsychologia 1995, 33:1143-1153.
40. Gray J.A., Joseph M.H., Hemsley D.R., Young A.M., Warburton E.C., Boulenguez P., Grigoryan G.A., Peters S.L., Rawlins J.N., Taib C.T., et al. The role of mesolimbic dopaminergic and retrohippocampal afferents to the nucleus accumbens in latent inhibition: implications for schizophrenia. Behav. Brain Res. 1995, 71:19-31.
41. Gresch P.J., Sved A.F., Zigmond M.J., Finlay J.M. Stress-induced sensitization of dopamine and norepinephrine efflux in medial prefrontal cortex of the rat. J. Neurochem. 1994, 63:575-583.
42. Gussew A., Rzanny R., Erdtel M., Scholle H.C., Kaiser W.A., Mentzel H.J., Reichenbach J.R. Time-resolved functional 1H MR spectroscopic detection of glutamate concentration changes in the brain during acute heat pain stimulation. NeuroImage 2010, 49:1895-1902.
43. Gussew A., Rzanny R., Gullmar D., Scholle H.C., Reichenbach J.R. 1H-MR spectroscopic detection of metabolic changes in pain processing brain regions in the presence of non-specific chronic low back pain. NeuroImage 2011, 54:1315-1323.
44. Gutzeit A., Meier D., Froehlich J.M., Hergan K., Kos S.C., Lutz V.W., Ettlin K., Binkert D., Mutschler C.A., Sartoretti-Schefer J., Brugger S.M. Differential NMR spectroscopy reactions of anterior/posterior and right/left insular subdivisions due to acute dental pain. Eur. Radiol. 2013, 23:450-460.
45. Haber S.N., Fudge J.L., McFarland N.R. Striatonigrostriatal pathways in primates form an ascending spiral from the shell to the dorsolateral striatum. J. Neurosci.: Off. J. Soc. Neurosci. 2000, 20:2369-2382.
46. Hagelberg N., Aalto S., Kajander J., Oikonen V., Hinkka S., Nagren K., Hietala J., Scheinin H. Alfentanil increases cortical dopamine D2/D3 receptor binding in healthy subjects. Pain 2004, 109:86-93.
47. Hagelberg N., Kajander J.K., Nagren K., Hinkka S., Hietala J., Scheinin H. Mu-receptor agonism with alfentanil increases striatal dopamine D2 receptor binding in man. Synapse 2002, 45:25-30.
48. Hagelberg N., Martikainen I.K., Mansikka H., Hinkka S., Nagren K., Hietala J., Scheinin H., Pertovaara A. Dopamine D2 receptor binding in the human brain is associated with the response to painful stimulation and pain modulatory capacity. Pain 2002, 99:273-279.
49. Hall H., Sedvall G., Magnusson O., Kopp J., Halldin C., Farde L. Distribution of D1- and D2-dopamine receptors, and dopamine and its metabolites in the human brain. Neuropsychopharmacol.: Off. Publ. Am. Coll. Neuropsychopharmacol. 1994, 11:245-256.
50. Hamner M.B., Diamond B.I. Elevated plasma dopamine in posttraumatic stress disorder: a preliminary report. Biol. Psychiatry 1993, 33:304-306.
51. Hermans E.J., Henckens M.J., Joels M., Fernandez G. Dynamic adaptation of large-scale brain networks in response to acute stressors. Trends Neurosci. 2014.
52. Hernaus D., Collip D., Kasanova Z., Winz O., Heinzel A., van Amelsvoort T., Shali S.M., Booij J., Rong Y., Piel M., Pruessner J., Mottaghy F.M., Myin-Germeys I. No evidence for attenuated stress-induced extrastriatal dopamine signaling in psychotic disorder. Transl. Psychiatry 2015, 5:e547.
53. Hernaus D., Collip D., Lataster J., Ceccarini J., Kenis G., Booij L., Pruessner J., Van Laere K., van Winkel R., van Os J., Myin-Germeys I. COMT Val158Met genotype selectively alters prefrontal [18F]fallypride displacement and subjective feelings of stress in response to a psychosocial stress challenge. PLOS ONE 2013, 8:e65662.
54. Hernaus D., Mehta M.A. Prefrontal cortex dopamine release measured in vivo with positron emission tomography: Implications for the stimulant paradigm. NeuroImage 2015.
55. Howes O.D., Kambeitz J., Kim E., Stahl D., Slifstein M., Abi-Dargham A., Kapur S. The nature of dopamine dysfunction in schizophrenia and what this means for treatment. Arch. General Psychiatry 2012, 69:776-786.
56. Howes O.D., Kapur S. The dopamine hypothesis of schizophrenia: version III - the final common pathway. Schizophr. Bull. 2009, 35:549-562.
57. Howes O.D., Murray R.M. Schizophrenia: an integrated sociodevelopmental-cognitive model. Lancet (London, England) 2014, 383:1677-1687.
58. Hsu D.T., Sanford B.J., Meyers K.K., Love T.M., Hazlett K.E., Walker S.J., Mickey B.J., Koeppe R.A., Langenecker S.A., Zubieta J.K. It still hurts: altered endogenous opioid activity in the brain during social rejection and acceptance in major depressive disorder. Mol. Psychiatry 2015, 20:193-200.
59. Hsu D.T., Sanford B.J., Meyers K.K., Love T.M., Hazlett K.E., Wang H., Ni L., Walker S.J., Mickey B.J., Korycinski S.T., Koeppe R.A., Crocker J.K., Langenecker S.A., Zubieta J.K. Response of the mu-opioid system to social rejection and acceptance. Mol. Psychiatry 2013, 18:1211-1217.
60. Imperato A., Puglisi-Allegra S., Casolini P., Angelucci L. Changes in brain dopamine and acetylcholine release during and following stress are independent of the pituitary-adrenocortical axis. Brain Res. 1991, 538:111-117.
61. Innis R.B., Cunningham V.J., Delforge J., Fujita M., Gjedde A., Gunn R.N., Holden J., Houle S., Huang S.C., Ichise M., Iida H., Ito H., Kimura Y., Koeppe R.A., Knudsen G.M., Knuuti J., Lammertsma A.A., Laruelle M., Logan J., Maguire R.P., Mintun M.A., Morris E.D., Parsey R., Price J.C., Slifstein M., Sossi V., Suhara T., Votaw J.R., Wong D.F., Carson R.E. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J. Cereb. Blood Flow Metab.: Off. J. Int. Soc. Cereb. Blood Flow Metab. 2007, 27:1533-1539.
62. Jahng J.W., Ryu V., Yoo S.B., Noh S.J., Kim J.Y., Lee J.H. Mesolimbic dopaminergic activity responding to acute stress is blunted in adolescent rats that experienced neonatal maternal separation. Neuroscience 2010, 171:144-152.
63. Joel D., Weiner I. The connections of the dopaminergic system with the striatum in rats and primates: an analysis with respect to the functional and compartmental organization of the striatum. Neuroscience 2000, 96:451-474.
64. Kambeitz J., Abi-Dargham A., Kapur S., Howes O.D. Alterations in cortical and extrastriatal subcortical dopamine function in schizophrenia: systematic review and meta-analysis of imaging studies. Br. J. Psychiatry: J. Mental Sci. 2014, 204:420-429.
65. Kegeles L.S., Abi-Dargham A., Zea-Ponce Y., Rodenhiser-Hill J., Mann J.J., Van Heertum R.L., Cooper T.B., Carlsson A., Laruelle M. Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia. Biol. Psychiatry 2000, 48:627-640.
66. King D., Zigmond M.J., Finlay J.M. Effects of dopamine depletion in the medial prefrontal cortex on the stress-induced increase in extracellular dopamine in the nucleus accumbens core and shell. Neuroscience 1997, 77:141-153.
67. Kobiella A., Vollstadt-Klein S., Buhler M., Graf C., Buchholz H.G., Bernow N., Yakushev I.Y., Landvogt C., Schreckenberger M., Grunder G., Bartenstein P., Fehr C., Smolka M.N. Human dopamine receptor D2/D3 availability predicts amygdala reactivity to unpleasant stimuli. Human Brain Mapp. 2010, 31:716-726.
68. Lappin J.M., Reeves S.J., Mehta M.A., Egerton A., Coulson M., Grasby P.M. Dopamine release in the human striatum: motor and cognitive tasks revisited. J. Cereb. Blood Flow Metab.: Off. J. Int. Soc. Cereb. Blood Flow Metab. 2009, 29:554-564.
69. Laruelle M. Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review. J. Cereb. Blood Flow Metab.: Off. J. Int. Soc. Cereb. Blood Flow Metab. 2000, 20:423-451.
70. Laruelle M., Abi-Dargham A., Gil R., Kegeles L., Innis R. Increased dopamine transmission in schizophrenia: relationship to illness phases. Biol. Psychiatry 1999, 46:56-72.
71. Lataster J., Collip D., Ceccarini J., Haas D., Booij L., van Os J., Pruessner J., Van Laere K., Myin-Germeys I. Psychosocial stress is associated with in vivo dopamine release in human ventromedial prefrontal cortex: a positron emission tomography study using [(1)(8)F]fallypride. NeuroImage 2011, 58:1081-1089.
72. Lataster J., Collip D., Ceccarini J., Hernaus D., Haas D., Booij L., van Os J., Pruessner J., Van Laere K., Myin-Germeys I. Familial liability to psychosis is associated with attenuated dopamine stress signaling in ventromedial prefrontal cortex. Schizophr. Bull. 2013, 40:66-77.
73. Lemieux A.M., Coe C.L. Abuse-related posttraumatic stress disorder: evidence for chronic neuroendocrine activation in women. Psychosom. Med. 1995, 57:105-115.
74. Love T.M., Enoch M.A., Hodgkinson C.A., Pecina M., Mickey B., Koeppe R.A., Stohler C.S., Goldman D., Zubieta J.K. Oxytocin gene polymorphisms influence human dopaminergic function in a sex-dependent manner. Biol. Psychiatry 2012, 72:198-206.
75. Martikainen I.K., Hagelberg N., Mansikka H., Hietala J., Nagren K., Scheinin H., Pertovaara A. Association of striatal dopamine D2/D3 receptor binding potential with pain but not tactile sensitivity or placebo analgesia. Neurosci. Lett. 2005, 376:149-153.
76. Martikainen I.K., Nuechterlein E.B., Pecina M., Love T.M., Cummiford C.M., Green C.R., Stohler C.S., Zubieta J.K. Chronic back pain is associated with alterations in dopamine neurotransmission in the ventral striatum. J. Neurosci.: Off. J. Soc. Neurosci. 2015, 35:9957-9965.
77. McEwen B.S. Stress, adaptation, and disease. Allostasis and allostatic load. Ann. N. Y. Acad. Sci. 1998, 840:33-44.
78. McEwen B.S. Protection and damage from acute and chronic stress: allostasis and allostatic overload and relevance to the pathophysiology of psychiatric disorders. Ann. N. Y. Acad. Sci. 2004, 1032:1-7.
79. Mickey B.J., Sanford B.J., Love T.M., Shen P.H., Hodgkinson C.A., Stohler C.S., Goldman D., Zubieta J.K. Striatal dopamine release and genetic variation of the serotonin 2C receptor in humans. J. Neurosci.: Off. J. Soc. Neurosci. 2012, 32:9344-9350.
80. Mizrahi R., Addington J., Rusjan P.M., Suridjan I., Ng A., Boileau I., Pruessner J.C., Remington G., Houle S., Wilson A.A. Increased stress-induced dopamine release in psychosis. Biol. Psychiatry 2012, 71:561-567.
81. Mizrahi R., Kenk M., Suridjan I., Boileau I., George T.P., McKenzie K., Wilson A.A., Houle S., Rusjan P. Stress-induced dopamine response in subjects at clinical high risk for schizophrenia with and without concurrent cannabis use. Neuropsychopharmacol.: Off. Publ. Am. Coll. Neuropsychopharmacol. 2014, 39:1479-1489.
82. Mizrahi R., Suridjan I., Kenk M., George T.P., Wilson A., Houle S., Rusjan P. Dopamine response to psychosocial stress in chronic cannabis users: a PET study with [11C]-+-PHNO. Neuropsychopharmacol.: Off. Publ. Am. Coll. Neuropsychopharmacol. 2013, 38:673-682.
83. Moghaddam B. Stress activation of glutamate neurotransmission in the prefrontal cortex: implications for dopamine-associated psychiatric disorders. Biol. Psychiatry 2002, 51:775-787.
84. Moher D., Liberati A., Tetzlaff J., Altman D.G. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009, 6:e1000097.
85. Monchi O., Ko J.H., Strafella A.P. Striatal dopamine release during performance of executive functions: a [(11)C] raclopride PET study. NeuroImage 2006, 33:907-912.
86. Montgomery A.J., Mehta M.A., Grasby P.M. Is psychological stress in man associated with increased striatal dopamine levels? A [11C]raclopride PET study. Synapse (New York, N.Y.) 2006, 60:124-131.
87. Moore K.E., Lariviere E.W. Effects of stress and d-amphetamine on rat brain catecholamines. Biochem. Pharmacol. 1964, 13:1098-1100.
88. Mullins P.G., Rowland L.M., Jung R.E., Sibbitt W.L. A novel technique to study the brain's response to pain: proton magnetic resonance spectroscopy. NeuroImage 2005, 26:642-646.
89. Murray R.M., Mehta M., Di Forti M. Different dopaminergic abnormalities underlie cannabis dependence and cannabis-induced psychosis. Biol. Psychiatry 2014, 75:430-431.
90. Myin-Germeys I., van Os J. Stress-reactivity in psychosis: evidence for an affective pathway to psychosis. Clin. Psychol. Rev. 2007, 27:409-424.
91. Nagano-Saito A., Dagher A., Booij L., Gravel P., Welfeld K., Casey K.F., Leyton M., Benkelfat C. Stress-induced dopamine release in human medial prefrontal cortex - 18F-fallypride/PET study in healthy volunteers. Synapse (New York, N.Y.) 2013, 67:821-830.
92. Pani L., Porcella A., Gessa G.L. The role of stress in the pathophysiology of the dopaminergic system. Mol. Psychiatry 2000, 5:14-21.
93. Pecina M., Azhar H., Love T.M., Lu T., Fredrickson B.L., Stohler C.S., Zubieta J.K. Personality trait predictors of placebo analgesia and neurobiological correlates. Neuropsychopharmacol.: Off. Publ. Am. Coll. Neuropsychopharmacol. 2013, 38:639-646.
94. Peciña M., Love T., Stohler C.S., Goldman D., Zubieta J.K. Effects of the Mu opioid receptor polymorphism (OPRM1 A118G) on pain regulation, placebo effects and associated personality trait measures. Neuropsychopharmacol.: Off. Publ. Am. Coll. Neuropsychopharmacol. 2014.
95. Peciña M., Martinez-Jauand M., Hodgkinson C., Stohler C.S., Goldman D., Zubieta J.K. FAAH selectively influences placebo effects. Mol. Psychiatry 2014, 19:385-391.
96. Peciña M., Martinez-Jauand M., Love T., Heffernan J., Montoya P., Hodgkinson C., Stohler C.S., Goldman D., Zubieta J.K. Valence-specific effects of BDNF Val66Met polymorphism on dopaminergic stress and reward processing in humans. J. Neurosci.: Off. J. Soc. Neurosci. 2014, 34:5874-5881.
97. Peciña M., Mickey B.J., Love T., Wang H., Langenecker S.A., Hodgkinson C., Shen P.H., Villafuerte S., Hsu D., Weisenbach S.L., Stohler C.S., Goldman D., Zubieta J.K. DRD2 polymorphisms modulate reward and emotion processing, dopamine neurotransmission and openness to experience. Cortex 2013, 49:877-890. (a journal devoted to the study of the nervous system and behavior).
98. Pertovaara A., Martikainen I.K., Hagelberg N., Mansikka H., Nagren K., Hietala J., Scheinin H. Striatal dopamine D2/D3 receptor availability correlates with individual response characteristics to pain. Eur. J. Neurosci. 2004, 20:1587-1592.
99. Poels E.M., Kegeles L.S., Kantrowitz J.T., Slifstein M., Javitt D.C., Lieberman J.A., Abi-Dargham A., Girgis R.R. Imaging glutamate in schizophrenia: review of findings and implications for drug discovery. Mol. Psychiatry 2014, 19:20-29.
100. Pruessner J.C., Champagne F., Meaney M.J., Dagher A. Dopamine release in response to a psychological stress in humans and its relationship to early life maternal care: a positron emission tomography study using [11C]raclopride. J. Neurosci.: Off. J. Soc. Neurosci. 2004, 24:2825-2831.
101. Pruessner J.C., Dedovic K., Khalili-Mahani N., Engert V., Pruessner M., Buss C., Renwick R., Dagher A., Meaney M.J., Lupien S. Deactivation of the limbic system during acute psychosocial stress: evidence from positron emission tomography and functional magnetic resonance imaging studies. Biol. Psychiatry 2008, 63:234-240.
102. Rittmaster R.S., Cutler G.B., Gold P.W., Brandon D.D., Tomai T., Loriaux D.L., Chrousos G.P. The relationship of saline-induced changes in vasopressin secretion to basal and corticotropin-releasing hormone-stimulated adrenocorticotropin and cortisol secretion in man. J. Clin. Endocrinol. Metab. 1987, 64:371-376.
103. Robinson T.E., Berridge K.C. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. Brain Res. Rev. 1993, 18:247-291.
104. Sapolsky R.M. Why Zebras Don't Get Ulcers 1994, WH Freeman, New York.
105. Scornaiencki R., Cantrup R., Rushlow W.J., Rajakumar N. Prefrontal cortical D1 dopamine receptors modulate subcortical D2 dopamine receptor-mediated stress responsiveness. Int. J. Neuropsychopharmacol.: Off. Sci. J. Coll. Int. Neuropsychopharmacol. (CINP) 2009, 12:1195-1208.
106. Scott D.J., Heitzeg M.M., Koeppe R.A., Stohler C.S., Zubieta J.K. Variations in the human pain stress experience mediated by ventral and dorsal basal ganglia dopamine activity. J. Neurosci.: Off. J. Soc. Neurosci. 2006, 26:10789-10795.
107. Scott D.J., Stohler C.S., Egnatuk C.M., Wang H., Koeppe R.A., Zubieta J.K. Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses. Arch. General Psychiatry 2008, 65:220-231.
108. Scott D.J., Stohler C.S., Koeppe R.A., Zubieta J.K. Time-course of change in [11C]carfentanil and [11C]raclopride binding potential after a nonpharmacological challenge. Synapse (New York, N.Y.) 2007, 61:707-714.
109. Slifstein M., van de Giessen E., Van Snellenberg J., Thompson J.L., Narendran R., Gil R., Hackett E., Girgis R., Ojeil N., Moore H., D'Souza D., Malison R.T., Huang Y., Lim K., Nabulsi N., Carson R.E., Lieberman J.A., Abi-Dargham A. Deficits in prefrontal cortical and extrastriatal dopamine release in schizophrenia: a positron emission tomographic functional magnetic resonance imaging study. JAMA Psychiatry 2015.
110. Soliman A., O'Driscoll G.A., Pruessner J., Holahan A.L., Boileau I., Gagnon D., Dagher A. Stress-induced dopamine release in humans at risk of psychosis: a [11C]raclopride PET study. Neuropsychopharmacol.: Off. Publ. Am. Coll. Neuropsychopharmacol. 2008, 33:2033-2041.
111. Spivak B., Vered Y., Graff E., Blum I., Mester R., Weizman A. Low platelet-poor plasma concentrations of serotonin in patients with combat-related posttraumatic stress disorder. Biol. Psychiatry 1999, 45:840-845.
112. St Onge J.R., Ahn S., Phillips A.G., Floresco S.B. Dynamic fluctuations in dopamine efflux in the prefrontal cortex and nucleus accumbens during risk-based decision making. J. Neurosci.: Off. J. Soc. Neurosci. 2012, 32:16880-16891.
113. Suridjan I., Boileau I., Bagby M., Rusjan P.M., Wilson A.A., Houle S., Mizrahi R. Dopamine response to psychosocial stress in humans and its relationship to individual differences in personality traits. J. Psychiatr. Res. 2012, 46:890-897.
114. Thierry A.M., Tassin J.P., Blanc G., Glowinski J. Selective activation of mesocortical DA system by stress. Nature 1976, 263:242-244.
115. Tidey J.W., Miczek K.A. Social defeat stress selectively alters mesocorticolimbic dopamine release: an in vivo microdialysis study. Brain Res. 1996, 721:140-149.
116. Varese F., Smeets F., Drukker M., Lieverse R., Lataster T., Viechtbauer W., Read J., van Os J., Bentall R.P. Childhood adversities increase the risk of psychosis: a meta-analysis of patient-control, prospective- and cross-sectional cohort studies. Schizophr. Bull. 2012, 38:661-671.
117. Vernaleken I., Peters L., Raptis M., Lin R., Buchholz H.G., Zhou Y., Winz O., Rosch F., Bartenstein P., Wong D.F., Schafer W.M., Grunder G. The applicability of SRTM in [(18)F]fallypride PET investigations: impact of scan durations. J. Cereb. Blood Flow Metab.: Off. J. Int. Soc. Cereb. Blood Flow Metab. 2011, 31:1958-1966.
118. Vrieze E., Ceccarini J., Pizzagalli D.A., Bormans G., Vandenbulcke M., Demyttenaere K., Van Laere K., Claes S. Measuring extrastriatal dopamine release during a reward learning task. Human Brain Mapp. 2013, 34:575-586.
119. Walker E.F., Diforio D. Schizophrenia: a neural diathesis-stress model. Psychol. Rev. 1997, 104:667-685.
120. Weiland B.J., Heitzeg M.M., Zald D., Cummiford C., Love T., Zucker R.A., Zubieta J.K. Relationship between impulsivity, prefrontal anticipatory activation, and striatal dopamine release during rewarded task performance. Psychiatry Res. 2014, 223:244-252.
121. Wenzel J.M., Rauscher N.A., Cheer J.F., Oleson E.B. A role for phasic dopamine release within the nucleus accumbens in encoding aversion: a review of the neurochemical literature. ACS Chem. Neurosci. 2015, 6:16-26.
122. Wood P.B., Schweinhardt P., Jaeger E., Dagher A., Hakyemez H., Rabiner E.A., Bushnell M.C., Chizh B.A. Fibromyalgia patients show an abnormal dopamine response to pain. Eur. J. Neurosci. 2007, 25:3576-3582.
123. Yehuda R., Southwick S., Giller E.L., Ma X., Mason J.W. Urinary catecholamine excretion and severity of PTSD symptoms in Vietnam combat veterans. J. Nerv. Mental Dis. 1992, 180:321-325.
124. Zubieta J.K., Smith Y.R., Bueller J.A., Xu Y., Kilbourn M.R., Jewett D.M., Meyer C.R., Koeppe R.A., Stohler C.S. Regional mu opioid receptor regulation of sensory and affective dimensions of pain. Science 2001, 293:311-315.